Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others), Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), Distribution Channel (Retail Ph
... and Region 2023-2028 Market Overview: The global dementia drugs market reached US$ 16.95 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.7 Billion by 2028, exhibiting a growth rate (CAGR) ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Neurotech Devices Market Size study & Forecast, by Product (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation Devices), by Conditions (Pain Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson’s Disease, Depression, Sleep Disorders, Essential Tremor), by End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities) and Regional Analysis, 2022-2029
... by End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities) and Regional Analysis, 2022-2029 Global Neurotech Devices Market is valued approximately USD 10.90 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Brain Implant Market By Type (Deep brain stimulation, Vagus nerve stimulation), By Application (Parkinson's disease, Epilepsy, Others), By End User (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... valued for $1.4 billion in 2022 and is estimated to reach $4.5 billion by 2032, exhibiting a CAGR of 12.2% from 2023 to 2032. A brain implant is a medical device that is surgically implanted ... Read More
-
Global Transcranial Magnetic Stimulator Market - 2023-2030
... at a CAGR of 9.2% during the forecast period (2023-2030). Transcranial Magnetic Stimulation is a noninvasive technological breakthrough involving applying short magnetic pulses to elicit nerve cells in brain regions associated with major depression, Alzheimer's, ... Read More
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Global Parkinson's Disease Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Parkinson's Disease sales for 2023 through 2029. With Parkinson's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Parkinson's Disease Therapeutics sales for 2023 through 2029. With Parkinson's Disease Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030
... Market Growth & Trends The global immunoassay for neurological biomarkers market size is expected to reach USD 2.24 billion by 2030, registering a CAGR of 17.8% from 2023 to 2030, according to a new report ... Read More
-
Neurodegenerative Drugs Market By Drug Class (Dopamine agonist , Decarboxylase inhibitors , Cholinesterase Inhibitors , Immunomodulators, Others ), By Indication (Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis , Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031 The neurodegenerative drugs market valued for $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, exhibiting a CAGR of ... Read More
-
Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Parkinson's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Vocal Biomarkers Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Frequency, Amplitude, Error Rate, Vocal Rise/Fall Time, Phonation Time, Voice Tremor, Pitch); By Indications (Depression, Attention Deficit, Disruptive Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
... Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle ... Read More
-
Global Parkinsons Disease Drugs Market Growth 2023-2029
... is used to transmit messages between the parts of the brain and nerves that control movement. LPI (LP Information)' newest research report, the “Parkinsons Disease Drugs Industry Forecast” looks at past sales and reviews total ... Read More
-
Global Parkinson's Disease Treatments Market Growth (Status and Outlook) 2023-2029
... this disease is mostly symptomatic and almost no curative treatment alternatives are available. LPI (LP Information)' newest research report, the “Parkinson's Disease Treatments Industry Forecast” looks at past sales and reviews total world Parkinson's Disease ... Read More
-
Parkinson's Disease Drugs Market by Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, COMT Inhibitors, MAO-B Inhibitors, Others), by Route of Administration (Oral, Injection, Transdermal), by Age Group (50 or below 50, Above 50 years): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Analysis and Industry Forecast, 2021-2031 The global Parkinson’s disease drugs market was valued at $5,689.12 million in 2021, and is projected to reach $10,402.65 million by 2031, registering a CAGR of 6.2% from 2021 to ... Read More
-
United States Brain Implants Market By Product Type (Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators) By Application (Chronic Pain, Epilepsy, Parkinson’s Disease, Depression, Essential Tremor, Alzheimer’s Disease) By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By Region, Competition Forecast & Opportunities, 2027
... Ambulatory Surgery Centers, Others) By Region, Competition Forecast & Opportunities, 2027 The United States brain implants market is anticipated to show robust growth in the upcoming five years, 2023-2027. The market growth can be attributed ... Read More
-
Blood-Brain Barrier Technologies Market Analysis And Forecast To 2032: By Application (Alzheimer Disease, Epilepsy, Parkinson Disease, Multiple Sclerosis, Hunter Syndrome, Brain Cancer), By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, Others), By End-Use (Hospitals, Surgical centers, Research Institutes, Others), And Region
... period. Blood-brain barrier (BBB) is one of the main components of the neurovascular unit and serves as the blood-brain interface to mediate communication between the central nervous system and the periphery. It prevents pathogens and ... Read More
-
Neurology Monitoring Market, By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Other Product Types), By Disease Type (Traumatic Brain Injury (TBI), Stroke, Sleep Disorders, Parkinson's Disease, Epilepsy, and Other Diseases), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and Other Diseases), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Neurology monitoring devices (such as Magnetic Resonance Imaging (MRI) ... Read More
-
Neurotech Devices Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region. Growing Number of Elderly Populations with Neurological Disorders The rapidly growing ... Read More
-
Brain Monitoring Market, By Product Type (Magnetoencephalograph, Electroencephalograph Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial pressure Monitoring Devices, and Other Product Types), By Application (Parkinson’s Disease, Traumatic Brain Injury Epilepsy, Dementia, and Sleep Disorders Other Applications), By End User (Hospitals and Diagnostic Centers), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Other Applications), By End User (Hospitals and Diagnostic Centers), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Brain monitoring is ... Read More
-
Deep Brain Stimulation Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Type (Open Loop DBS, Closed Loop DBS); Distribution Channel (Online, Offline); End User (Hospitals, Specialized Neurology Clinics, Research Centers, Others); Functionality (One-sided Dual Channel Deep Brain Stimulator, Two-sided Dual Channel Deep Brain Stimulator); Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others); Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Research Centers, Others); Functionality (One-sided Dual Channel Deep Brain Stimulator, Two-sided Dual Channel Deep Brain Stimulator); Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others); Region (North America, Europe, Asia Pacific, Latin America, ... Read More
-
SARM1 Targeting Therapeutics Market, 2022-2040
... annually. Further, according to a report published by the United Nations (UN), close to 1 billion people, globally, suffer from various types of neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and ... Read More
-
Electrophysiology Market Size By Product (EP Ablation Catheters {Radiofrequency, Cryoablation, Laser}, EP Diagnostic Catheters {Conventional, Advanced, Ultrasound}, EP Laboratory Devices {Mapping Systems, Recording Systems}), By Indication (Atrial Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Atrial Flutter, WOLFF-Parkinson-White (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia), By End-use (Hospitals, Catheterization Laboratories/EP Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia), By End-use (Hospitals, Catheterization Laboratories/EP Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 The electrophysiology industry is anticipated ... Read More
-
Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Carbidopa-levodopa, Anticholinergics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2022 - 2030
... & Trends The global Parkinson’s disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from ... Read More
-
Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027Segmented By Biomarkers (Genetic v/s Protein), By Sample (Blood Based v/s Non-Blood-Based), By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others), By Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Others), By End User (Hospital & Clinics, Academic & Research Institutions, Others), By Company and By Region
... (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Others), By End User (Hospital & Clinics, Academic & Research Institutions, Others), By Company and By Region The global precision psychiatry market is anticipated to observe impressive growth during ... Read More
Research Assistance
